We meta-analyzed the relationship between depression and HIV medication nonadherence
to calculate the overall effect size and examine potential moderators. Overall, across 95 …

Knowledge of factors associated with medication adherence could help HIV clinicians to
target persons in need of intervention, design these interventions, and help researchers to …

The purpose of the present study was to identify variables relevant to psychological well-
being in HIV patients receiving highly active antiretroviral therapy (HAART). Multiple …

Background: Adherence to prescribed medications is a central feature of good clinical HIV
care, but little is known about the factors associated with multidrug antiretroviral adherence …

INTRODUCTION: The prevalence of depressive disorders in HIV-infected patients ranges
from 12% to 66% and is undiagnosed in 50% to 60% of these patients. Depression in HIV …

Objective: To examine the association of social, health, and poverty-related stressors in
relation to antiretroviral therapy adherence in a sample of people with low-literacy living with …

Objectives: To describe changes in HIV-associated neurocognitive impairment in patients
treated with highly active antiretroviral therapy (HAART) for at least 3 years. Methods …

High levels of adherence to antiretroviral medications are required to maximize therapeutic
benefits and viral suppression. Injecting drug use (IDU) is associated with decreased …

Objective: To determine if HIV/AIDS-specific quality of life (QOL) predicts adherence to
antiretroviral therapy (ART). Methods: HIV-infected outpatients on efavirenz plus 2 or 3 …

OBJECTIVE: To distinguish the effects of drug abuse, mental disorders, and problem
drinking on antiretroviral therapy (ART) and highly active ART (HAART) use. DESIGN …